Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03113643 |
|---|---|
| Brief Title: | SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) |
| First Submitted : | April 10, 2017 |
| First Submitted that Met QC Criteria : | April 10, 2017 |
| First Posted : | April 13, 2017 |
| Last Update Submitted that Met QC Criteria : | June 19, 2023 |
| Last Update Posted : | June 22, 2023 |